ELMD

$23.95+0.16 (+0.67%)

Market OpenAs of Mar 17, 4:12 PM UTC

Electromed, Inc.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$23.95
Potential Downside
5.2%
Whystock Fair Value$22.70
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Devices

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The co...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$199.76M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
23.25
Beta
Defensive asset. Lower volatility than the S&P 500.
0.31
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Elite ROE. Management converts capital into profit efficiently.
20.20%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
4.39

Recent News

Insider Monkey
Mar 4, 2026

Electromed (ELMD) Reports 13th Consecutive Quarter of Revenue and Profit Growth

Electromed Inc. (NYSEAMERICAN:ELMD) is one of the most promising micro-cap stocks according to analysts. On February 10, Electromed achieved its 13th consecutive quarter of year-over-year revenue and profit growth, reporting record net revenues of $18.9 million for FQ2 2026. This 16.3% increase was primarily driven by the company’s core home care business, which grew 18.4% […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 2, 2026

3 Reasons Growth Investors Will Love Electromed (ELMD)

Electromed (ELMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Feb 24, 2026

Zacks Industry Outlook Highlights Intuitive Surgical, Edwards Lifesciences and Electromed

Intuitive Surgical, Edwards and Electromed tap GenAI tailwinds as AI healthcare spending surges, despite industry under performance.

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
Zacks
Feb 23, 2026

3 Medical Instrument Stocks Banking on GenAI to Tackle Industry Woes

ISRG, EW and ELMD tap GenAI to enhance diagnostics and workflows, even as MedTech faces cost pressures, data risks and macro headwinds.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
GuruFocus.com
Feb 13, 2026

Electromed Inc (ELMD) Q2 2026 Earnings Call Highlights: Record Revenue and Strategic Growth ...

Electromed Inc (ELMD) reports a robust 16.3% revenue growth and a 42.4% increase in operating income, while navigating declines in hospital channel revenue and expanding market reach.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.